Diseases / Hepatocellular Carcinoma
Hepatocellular Carcinoma
Disease- Registered trials
- 1840
- Ongoing
- 524/ 28%
- Completed
- 582
Clinical trial landscape
1840 registered studies reference this disease. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Unknown | 443 | 129 | 168 | |
| Phase 2 | 442 | 132 | 132 | |
| Not applicable | 347 | 105 | 106 | |
| Phase 1 | 196 | 60 | 61 | |
| Phase 3 | 153 | 40 | 44 | |
| Phase 1/2 | 128 | 33 | 39 | |
| Phase 4 | 57 | 7 | 19 | |
| Phase 2/3 | 47 | 13 | 4 | |
| Early Phase 1 | 27 | 5 | 9 | |
| All phases | 1840 | 524 | 582 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Recent developments
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.